Research programme: oncolytic viruses - GeronAlternative Names: Ad2/phTERT-E1A; OV1060
Latest Information Update: 17 Jul 2007
At a glance
- Originator Geron Corporation
- Class Oncolytic viruses
- Mechanism of Action Telomerase inhibitors
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
On Fast track
Fast track status is assigned by the US FDA so therapies with the potential to address unmet needs can move faster through development.
Highest Development Phases
- Preclinical Cancer